Cargando…
Update on the Management of Stage III NSCLC: Navigating a Complex and Heterogeneous Stage of Disease
Background: Stage III nonsmall cell lung cancer (NSCLC) represents a heterogeneous group of patients. Many patients are treated with curative intent multimodality therapy, either surgical resection plus systemic therapy or chemoradiation plus immunotherapy. However, many patients are not suitable fo...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670056/ https://www.ncbi.nlm.nih.gov/pubmed/37999109 http://dx.doi.org/10.3390/curroncol30110689 |